During the past decade, NZOZ Clinica Vitae conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Clinica Vitae" #1 collaborator was "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Clinica Vitae" are "Asthma" (1 trials) and "Birch Pollen Induced Rhinitis/Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "NZOZ Clinica Vitae" in a lesser frequency.

Most popular intervention types in "NZOZ Clinica Vitae" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Revamilast" (1 trials) and "SUBLIVAC FIX Birch" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Clinica Vitae" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Clinica Vitae". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NZOZ Clinica Vitae, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Clinica Vitae, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".